InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+13.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by snyderman nancy lynn MD, Director. Officer active across 3 companies, notably Alkermes plc.. In total, 18 disclosures have been logged. Split: 1 buy · 1 sell. Total volume traded: €2m. Activity tracked since 20 May 2021. The latest transaction was filed on 3 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to snyderman nancy lynn MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
27,948 shares@ US$46.720.016% mcap29.8% of flowOrdinary SharesSEC:0001520262-26-000111:0
16,524 shares@ US$46.720.0094% mcap17.6% of flowOrdinary SharesSEC:0001520262-26-000111:1
44,472 shares@ US$50.3480.027% mcap51.1% of flowOrdinary SharesSEC:0001520262-26-000111:2
6,142 sharesOrdinary SharesSEC:0001520262-26-000091:0
1,475 shares@ US$36.950.0010% mcap83.8% of flowOrdinary SharesSEC:0001520262-26-000091:1
8,013 sharesOrdinary SharesSEC:0001127602-25-016204:0
14,944 shares@ US$71.00100.0% of flowCommon StockSEC:0001562180-24-007710:0
5,000 shares0Common StockSEC:0001562180-24-007659:0
6,104 sharesOrdinary SharesSEC:0001127602-24-019603:0
5,957 sharesOrdinary SharesSEC:0001127602-23-020550:0
3,000 shares0Common StockSEC:0001562180-23-005532:0
2,100 shares0Common StockSEC:0001562180-22-006264:0
7,585 sharesOrdinary SharesSEC:0001127602-22-017639:0
427 shares@ US$23.430.0002% mcap100.0% of flowOrdinary SharesSEC:0001127602-22-008576:0
Canonical exit: 2 Jun 2022 (T+90)
5,578 sharesOrdinary SharesSEC:0001127602-21-030303:0
2,261 shares0Common StockSEC:0001562180-21-006778:0
1,688 shares0Common stock, par value $0.0001 per shareSEC:0001104659-21-129991:0
6,104 shares0Ordinary SharesSEC:0001127602-21-017790:0
18 of 18 declarations
About snyderman nancy lynn MD
Nancy Lynn Snyderman MD is Administrateur at Alkermes plc., Axonics, Inc. and Future Health ESG Corp. She has 15 filings in total, and across the sampled recent filings from 2021-05-21 to 2026-05-22, the stated amounts are 9040 in buys and 1007612 in sells, with Levée d'options as the dominant transaction nature.
